REVB

NASDAQ 已收盘

Revelation Biosciences

3.50 USD
▼-0.19-5.15%
盘后 3.55 +1.54%
2026-11-20
市值
$2.39M
市盈率
—
EPS
-39.97
股息率
—
52 周区间
3.08 – 40.60
成交量
9.79K
Beta
-0.10
目标价
65.75
52W 低 3.0852W 高 40.60
价格走势

公司简介

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the...